Peer-influenced content. Sources you trust. No registration required. This is HCN.

Features:
CME JOBS OUTBREAKS PEER-TO-PEER QUIZZES & QUESTIONS MEDTECH

Articles related to INTRAOCULAR PRESSURE (IOP)

Eyetube

New Year, New Eye Care Innovation

Marc R. Bloomenstein, OD, FAAO examines the status of various ophthalmic medications in the first video of 2023, including preservative-free latanoprost for IOP reduction (IYUZEH, Thea Pharma), MydCombi (Eyenovia) for in-office pupil dilatation, and others.

Ophthalmology January 26th 2023

Tags: INTRAOCULAR PRESSURE (IOP) PEER-TO-PEER VISION CARE

Topics

Sources

ACP Internist
Annals of Internal Medicine
ASH Clinical News
Blood
Blood Advances
British Medical Journal
Cancer Therapy Advisor
Cleveland Clinic Journal of Medicine
Clinical Advances in Hematology & Oncology
GoodRx Health
Healthgrades for Professionals
JAMA Network
Journal of Clinical Oncology
MDLinx
MedPage Today
Monthly Prescribing Reference (MPR)
Neurology Advisor
Psychiatrist.com
ReachMD
The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form